A Arumugam-Sivakumar

Vellore, TN 632014, India

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

Ubiquitination and deubiquitination as critical modulators of NSCLC tumorigenesis and drug resistance.

Ubiquitination and deubiquitination as critical modulators of NSCLC tumorigenesis and drug resistance.

Journal: Discover oncology

Published: September 07, 2025

Transforming growth factor-β and integrins: key players in EMT and breast cancer progression.

Transforming growth factor-β and integrins: key players in EMT and breast cancer progression.

Journal: Cancer cell international

Published: September 02, 2025

Transforming growth factor-β and integrins: key players in EMT and breast cancer progression.

Transforming growth factor-β and integrins: key players in EMT and breast cancer progression.

Journal: Cancer cell international

Published: September 02, 2025

Repurposing DPP-4 inhibitors as anticancer agents in KRAS-mutated pancreatic ductal adenocarcinoma.

Repurposing DPP-4 inhibitors as anticancer agents in KRAS-mutated pancreatic ductal adenocarcinoma.

Journal: BMC pharmacology & toxicology

Published: May 24, 2025

A machine learning-Assisted QSAR and integrative computational combined with network pharmacology approach for rational identification of tankyrase inhibitors in colon adenocarcinoma.

A machine learning-Assisted QSAR and integrative computational combined with network pharmacology approach for rational identification of tankyrase inhibitors in colon adenocarcinoma.

Journal: Computers in biology and medicine

Published: April 10, 2025

Pharmacophore-based identification and in Silico characterization of microbial metabolites as potential modulators of Wnt signaling pathway in colorectal cancer therapy.

Pharmacophore-based identification and in Silico characterization of microbial metabolites as potential modulators of Wnt signaling pathway in colorectal cancer therapy.

Journal: Molecular diversity

Published: November 23, 2024

Design and development of dual targeting CAR protein for the development of CAR T-cell therapy against KRAS mutated pancreatic ductal adenocarcinoma using computational approaches.

Design and development of dual targeting CAR protein for the development of CAR T-cell therapy against KRAS mutated pancreatic ductal adenocarcinoma using computational approaches.

Journal: Discover oncology

Published: July 24, 2024

Exploring putative drug properties associated with TNF-alpha inhibition and identification of potential targets in cardiovascular disease using machine learning-assisted QSAR modeling and virtual reverse pharmacology approach.

Exploring putative drug properties associated with TNF-alpha inhibition and identification of potential targets in cardiovascular disease using machine learning-assisted QSAR modeling and virtual reverse pharmacology approach.

Journal: Molecular diversity

Published: May 05, 2024

Reverse vaccinology and immunoinformatics approaches to design multi-epitope based vaccine against oncogenic KRAS.

Reverse vaccinology and immunoinformatics approaches to design multi-epitope based vaccine against oncogenic KRAS.

Journal: Medical oncology (Northwood, London, England)

Published: June 29, 2023

Therapeutic investigations of novel indoxyl-based indolines: A drug target validation and Structure-Activity Relationship of angiotensin-converting enzyme inhibitors with cardiovascular regulation and thrombolytic potential.

Therapeutic investigations of novel indoxyl-based indolines: A drug target validation and Structure-Activity Relationship of angiotensin-converting enzyme inhibitors with cardiovascular regulation and thrombolytic potential.

Journal: European journal of medicinal chemistry

Published: June 09, 2017

Efficacy of phenyl quinoline phenol derivatives as COX-2 inhibitors; an approach to emergent the small molecules as the anti-inflammatory and analgesic therapeutics.

Efficacy of phenyl quinoline phenol derivatives as COX-2 inhibitors; an approach to emergent the small molecules as the anti-inflammatory and analgesic therapeutics.

Journal: Inflammopharmacology

Published: December 30, 2016

Molecular explorations of substituted 2-(4-phenylquinolin-2-yl) phenols as phosphoinositide 3-kinase inhibitors and anticancer agents.

Molecular explorations of substituted 2-(4-phenylquinolin-2-yl) phenols as phosphoinositide 3-kinase inhibitors and anticancer agents.

Journal: Cancer chemotherapy and pharmacology

Published: September 16, 2016

Showing 1-12 of 12

Last Updated: 09/26/2026